Search results
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Finance· 9 minutes agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 2 hours agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 1 hour agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, ...
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
WKBN 27 Youngstown· 1 day ago("Biogen Inc." or "the Company") (NASDAQ: BIIB) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal ...
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance· 3 days agoIt is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of...
Morningstar· 1 day agoThe Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (“Biogen” or the “Company ...
... Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit...
Morningstar· 20 hours agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The class action, filed ...
European Commission grants marketing approval to Biogen's ALS drug
Reuters· 18 hours ago, opens new tab said on Thursday that the European Commission has granted marketing authorization...
BIOGEN ALERT: BFA Law Announces Biogen Inc. (Nasdaq: BIIB) Sued for Securities Fraud after...
Morningstar· 2 days agoNEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities ...
RBC maintains $317 price target on Biogen stock, cites Skyclarys importance By Investing.com
Investing.com· 2 days agoOn Wednesday, RBC (TSX:RY) Capital maintained its Outperform rating on Biogen (NASDAQ:BIIB) shares...